other

Updated:

SC Laboratories

Jeff Gray co-founded SC Laboratories in 2010, building the largest multi-state cannabis and hemp testing platform in the US, processing over 740,000 tests.

SC Laboratories

Cannabis and hemp testing and analysis you can use to build your reputation and grow your business.

Website
sclabs.com

General information

Firm type

other

Year founded

2010

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Santa Cruz

Corporate office

Santa Cruz, CA, United States

Additional offices

Arizona · Oregon · Colorado · Michigan

Principals

Jeff Gray

Chief Executive Officer

Alec Dixon

Executive VP, Client Relations

Ryan DeCurtis

Senior VP, Technology

Sector focus

CannabisAgriTech & FoodTechHealthcare Services

Frequently asked questions

Who runs investment and strategic decisions at SC Laboratories?

Jeff Gray serves as CEO, Alec Dixon is Executive VP of Client Relations, and Ryan DeCurtis is Senior VP of Technology. The three co-founders — Gray, Dixon, and Josh Wurzer (Chief Operating Officer) — have shaped the firm's direction since 2010. The company also maintains a board of advisors including Shaun Kelley, Amy McDonald, Mike Branvold, and Hirsh Jain.

How does SC Laboratories source business outside its home state of California?

SC Laboratories operates cannabis testing facilities in Arizona, Oregon, Colorado, and Michigan, and runs a national hemp testing panel registered in Idaho, Illinois, New Mexico, New York, and Texas. Multi-state cannabis operators contract with SC Labs across these jurisdictions, while hemp clients can ship samples to the national panel regardless of their home state. The firm's R&D Center of Excellence in Santa Cruz supports all locations.

Is SC Laboratories a pure-play testing lab, or does it have exposure to cannabis plant-touching operations?

SC Laboratories is a pure-play testing lab. It does not cultivate, manufacture, distribute, or sell cannabis or hemp products. Its sole revenue source is laboratory testing fees, which structurally insulates it from conflicts that could arise if it were vertically integrated with operators whose products it tests.

What testing services does SC Laboratories provide?

The lab performs potency analysis, terpene profiling, pesticide screening, heavy metals testing, residual solvents analysis, and microbiological contamination detection. Its chemometric terpene reporting categorizes strains by chemical profile rather than the traditional indica/sativa/hybrid taxonomy, a shift the firm has advocated publicly since at least 2023. On the hemp side, it also tests for Delta-8 THC adulterants and synthesis byproducts.

Does SC Laboratories have a known philanthropic or corporate venture arm?

No philanthropic foundation, corporate venture arm, or adjacent investment vehicle has been publicly disclosed. The firm's public footprint is limited to its operating labs, content marketing through its blog, and advocacy work by its principals on terpene categorization and federal hemp testing standards.

What is SC Laboratories' known posture on co-investments or partnerships with external entities?

SC Laboratories has not disclosed any co-investment vehicles, partnership funds, or external investment positions. It presents itself as an independent operating company serving growers, extractors, product makers, and retailers. Its board of advisors includes individuals from outside the firm, but the nature of their engagement has not been characterized as investment-related.

How does SC Laboratories compare to other multi-state cannabis testing labs?

SC Laboratories claims to be the largest multi-state cannabis testing lab by facility count and geographic reach, with active cannabis labs in five states and registered hemp testing in five additional states. Its chemometric terpene reporting system and a stated data set of over 740,000 tests differentiate it from labs that report only potency and safety metrics. The firm's public advocacy for retiring the indica/sativa classification and for federal hemp testing harmonization adds an industry-standard-setting dimension not commonly seen among regional competitors.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Santa Cruz other profiles